ANAB stock

AnaptysBio Inc (ANAB) financials · $1.62B cap

Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT

AnaptysBio Inc (ANAB) $1.62B cap.

Cached income statement (latest stored periods)
LineQ1 2026Q3 2025
Revenue$25.6M$76.3M
Operating Income-$34.6M$34.7M
Net Income-$52.9M$15.1M
EPS (Diluted)-$1.84$0.52
Cached balance sheet (latest stored periods)
LineQ1 2026FY2025
Total Assets$329.7M$364.4M
Current Assets$316.1M$350.3M
Cash & Equivalents$248.5M$238.2M
PP&E$1.28M$1.37M
Total Liabilities$316.9M$327.2M
Current Liabilities$41.7M$38.6M
Shareholders' Equity$12.7M$37.2M
Retained Earnings-$825.4M-$772.6M
Cached annual cash flow
LineFY2026FY2025
Operating Cash Flow-$52.6M$19.7M
CapExN/A$87.0K
Investing Cash Flow$42.5M$228.0M
Financing Cash Flow-$94.4M-$132.6M
Net Change in Cash-$104.4M$115.1M
Free Cash FlowN/A$19.6M
These statements as JSON? API free 100/day

FAQ

What is ANAB P/E and revenue?

AnaptysBio Inc (ANAB) $1.62B cap.

What is ANAB revenue?

AnaptysBio Inc last cached revenue is $25.6M (Q1 2026).

Is ANAB profitable?

AnaptysBio Inc last cached net income is -$52.9M (Q1 2026).

What are ANAB total assets?

AnaptysBio Inc last cached total assets are $329.7M (Q1 2026).

What is ANAB free cash flow?

No cached cash-flow row for ANAB yet.

Not investment advice. Cached statements, not a live tape.